专题:Viral Infectious Diseases and Gene Expression in Insects

This cluster of papers focuses on the production of recombinant proteins, particularly in mammalian and insect cells. It covers topics such as transient transfection, baculovirus expression systems, glycosylation, virus-like particles, and monoclonal antibody production. The research also delves into cell culture processes and biopharmaceutical production.
最新文献
Tumor-Specific AAV Delivery of Interleukin-12 Enhances Antitumor Immunity and Safety in Ovarian Cancer Xenograft Mouse Model

article Full Text OpenAlex

Optimal Structural Designs of Trispecific Antibodies to Enhance Therapeutic Efficacy in Solid Tumors and Hematological Malignancies

article Full Text OpenAlex

From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy

review Full Text OpenAlex

Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure

article Full Text OpenAlex

Two-stage CD8+ CAR T-cell differentiation in patients with large B-cell lymphoma

article Full Text OpenAlex

Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study

article Full Text OpenAlex

Antibody Oxidation and Impact of Formulation: A High-Throughput Screening Approach

article Full Text OpenAlex

Unfolding of viral protein 1 N-termini facilitates genome ejection from recombinant adeno-associated virus serotype 8

article Full Text OpenAlex

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

article Full Text OpenAlex

A Review on the Stability Challenges of Advanced Biologic Therapeutics

review Full Text OpenAlex

近5年高被引文献
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

article Full Text OpenAlex 1791 FWCI164.17

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

article Full Text OpenAlex 1221 FWCI110.325

Translational Applications of Hydrogels

review Full Text OpenAlex 747 FWCI15.238

CB-Dock2: improved protein–ligand blind docking by integrating cavity detection, docking and homologous template fitting

article Full Text OpenAlex 738 FWCI118.685

Long-term outcomes following CAR T cell therapy: what we know so far

review Full Text OpenAlex 668 FWCI55.478

Recent advances and discoveries in the mechanisms and functions of CAR T cells

review Full Text OpenAlex 655 FWCI21.32

Cytokines: From Clinical Significance to Quantification

review Full Text OpenAlex 630 FWCI15.011

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

article Full Text OpenAlex 586 FWCI88.224

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

article Full Text OpenAlex 436 FWCI39.042

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

review Full Text OpenAlex 427 FWCI19.767